PolarityTE, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTE research report →
Companywww.polarityte.com
PolarityTE, Inc. , a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services.
- CEO
- Richard Hague
- IPO
- 1999
- Employees
- 42
- HQ
- Salt Lake City, UT, US
Price Chart
Valuation
- Market Cap
- $1.78M
- P/E
- 0.16
- P/S
- 2.18
- P/B
- 0.10
- EV/EBITDA
- 1.01
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 24.32%
- Op Margin
- -3178.99%
- Net Margin
- 1254.42%
- ROE
- 56.95%
- ROIC
- 157.14%
Growth & Income
- Revenue
- $814.00K · -91.34%
- Net Income
- $10.21M · 136.19%
- EPS
- $1.49 · 116.91%
- Op Income
- $-25,877,000
- FCF YoY
- 0.52%
Performance & Tape
- 52W High
- $1.90
- 52W Low
- $0.20
- 50D MA
- $0.41
- 200D MA
- $0.67
- Beta
- 1.15
- Avg Volume
- 267.68K
Get TickerSpark's AI analysis on PTE
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 26, 23 | Dyer Jeffrey Hansen | other | 42,986 |
| Jan 26, 23 | Dyer Jeffrey Hansen | other | 200 |
| Jan 26, 23 | Dyer Jeffrey Hansen | other | 0 |
| Jan 12, 23 | Nolet Chris | other | 36,497 |
| Jan 12, 23 | Nolet Chris | other | 3,078 |
| Oct 1, 22 | Seaburg David B | other | 50,900 |
| Oct 1, 22 | Nolet Chris | other | 50,900 |
| Oct 1, 22 | COHEN PETER A | other | 50,900 |
| Oct 1, 22 | Bogan Willie C. | other | 50,900 |
| Aug 17, 22 | COHEN PETER A | sell | 8,555 |
Our PTE Coverage
We haven't published any research on PTE yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PTE Report →